Homeopathy 2026; 115(01): A1-A26
DOI: 10.1055/s-0046-1817115
Poster Presentation Abstracts

Concurrent Utilization and Medication Adherence of Arsenicum album 30C as Prophylactic Against COVID-19: A Cross-Sectional, Community-Based Study

Authors

  • Debadatta Nayak

    1   Central Council for Research in Homoeopathy, New Delhi, India
  • Karanpreet Nahar

    2   Pan-India COVID-19 Study Group
  • Lovepreet Kaur

    2   Pan-India COVID-19 Study Group
  • Smita Singh

    2   Pan-India COVID-19 Study Group
  • Hima Bindu Ponnam

    2   Pan-India COVID-19 Study Group
  • Birendra Rawat

    2   Pan-India COVID-19 Study Group
  • Akhyaya Prusty

    2   Pan-India COVID-19 Study Group
  • Umakanta Prusty

    2   Pan-India COVID-19 Study Group
  • Liyi Karso

    2   Pan-India COVID-19 Study Group
  • Lipipushpa Debata

    2   Pan-India COVID-19 Study Group
  • Siva Prasad Goli

    2   Pan-India COVID-19 Study Group
  • Baidurjya Bhattacharjee

    2   Pan-India COVID-19 Study Group
  • Bezawada Brunda

    2   Pan-India COVID-19 Study Group
  • Partha Pratim Pal

    2   Pan-India COVID-19 Study Group
  • Karthikeyan Devarajan

    2   Pan-India COVID-19 Study Group
  • Nidhi Mahajan

    2   Pan-India COVID-19 Study Group
  • Santi Adhikary

    2   Pan-India COVID-19 Study Group
  • Santosh Tamang

    2   Pan-India COVID-19 Study Group
  • Amit Shrivastava

    2   Pan-India COVID-19 Study Group
  • Ratan Shil

    2   Pan-India COVID-19 Study Group
  • Karunakara Moorthi

    2   Pan-India COVID-19 Study Group
  • Vibha Kumari

    2   Pan-India COVID-19 Study Group
  • Uttam Singh

    2   Pan-India COVID-19 Study Group
  • Nitin Saklani

    2   Pan-India COVID-19 Study Group
 

Background:Arsenicum album 30C was recommended by the Government of India as a COVID-19 prophylactic. During the Azadi ka Amrit Mahotsav (AKAM) program from September 2021 to August 2022, 3.5 million people received Arsenicum album 30C. This study aimed to estimate its utilization in the general population as a prophylactic.

Methods: A multi-centric pan-India cross-sectional study on drug utilization involved 23,101 participants from 23 cities between September and November 2022. To reduce recall bias, only those who received the medicine within the last month were enrolled. Health workers randomly approached the public for consent. The main outcome was adherence to Arsenicum album 30C over the past month, self-reported by participants. Those who took all three scheduled doses were classified as having perfect adherence; those who took one or two doses had partial adherence; and those who took none were categorized as having no adherence.

Results: Out of 23,101 participants, 79.89% (n = 18,457) showed perfect medication adherence by completing the three-dose prophylactic schedule. Partial or no adherence was seen in 16.81% (n = 3,885) and 3.28% (n = 759), respectively. The multivariate binary logistic regression analysis, adjusting for confounding factors, indicated that participants aged 18 to 40 [adjusted odds ratio (aOR) 1.35 (1.20–1.52)], those from the upper socioeconomic class [aOR 1.71 (1.19–2.48)], and COVID-19 vaccinated individuals [aOR 1.64 (1.35–2.01), p = 0.0001] had higher perfect adherence. The main reason for non-adherence was forgetfulness [52.08% (n = 2,419)].

Conclusion: This study indicates high adherence to the three-dose regimen among COVID-19 vaccinated individuals, emphasizing the effectiveness of government distribution programs in promoting public health compliance. Future research should examine longitudinal trends, address unintentional non-adherence, and explore homeopathy’s role in public health.

Keywords: Arsenicum, COVID-19, drug utilization, homeopathy



Publication History

Article published online:
03 February 2026

© 2026. Faculty of Homeopathy. This article is published by Thieme.

Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany